Transient mRNA CAR T Cells Targeting Gd2 Provide Dose-Adjusted Efficacy Against Diffuse Midline Glioma And High Grade Glioma Models
Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models.
Previous PostGenetic Ancestry Superpopulations Show Distinct Prevalence And Outcomes Across Pediatric Central Nervous System Tumors From The Pediatric Brain Tumor Atlas And Pediatric Neuro-Oncology Consortium
Next PostTelomere Length Analysis of CNS Tumors in the Pediatric Brain Tumor Atlas
Apply to the CBTN Fellowship Program by completing the information below and uploading your one-page project proposal and current CV. Applications are reviewed on a rolling basis.
NOTE: The CBTN Fellowship Program is a research mentorship and engagement opportunity, not a grant or direct funding program.
